Allianz Asset Management GmbH - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2023$2,136,645
+342.2%
290,700
+523.2%
0.00%
+300.0%
Q1 2023$483,221
-9.4%
46,643
+3.3%
0.00%0.0%
Q4 2022$533,139
-46.6%
45,143
+96.4%
0.00%0.0%
Q4 2021$999,000
-40.2%
22,984
-31.1%
0.00%0.0%
Q3 2021$1,671,000
+11.5%
33,380
+40.4%
0.00%0.0%
Q2 2021$1,498,000
-29.5%
23,775
+3.9%
0.00%
-50.0%
Q1 2021$2,125,000
+42.8%
22,872
+37.7%
0.00%
+100.0%
Q4 2020$1,488,000
-61.3%
16,612
-55.4%
0.00%
-75.0%
Q3 2020$3,846,000
+33.9%
37,218
+2.5%
0.00%
+33.3%
Q2 2020$2,872,000
+39.3%
36,316
+2.0%
0.00%0.0%
Q1 2020$2,061,000
+122.1%
35,616
+107.0%
0.00%
+200.0%
Q4 2019$928,000
+4.9%
17,204
+1.5%
0.00%0.0%
Q3 2019$885,000
-12.7%
16,942
-19.3%
0.00%0.0%
Q2 2019$1,014,000
-83.1%
20,988
-82.3%
0.00%
-83.3%
Q1 2019$5,997,000
+1.6%
118,714
+19.2%
0.01%0.0%
Q4 2018$5,904,000
-12.6%
99,599
-2.9%
0.01%0.0%
Q3 2018$6,754,000
+27.8%
102,608
-2.0%
0.01%
+20.0%
Q2 2018$5,285,000
-11.1%
104,672
-7.3%
0.01%
-16.7%
Q1 2018$5,942,000
+82.3%
112,858
+60.9%
0.01%
+100.0%
Q4 2017$3,259,000
+18.6%
70,130
+3.3%
0.00%
+50.0%
Q3 2017$2,747,000
+19.1%
67,913
-0.4%
0.00%0.0%
Q2 2017$2,306,000
+3.4%
68,203
-11.2%
0.00%0.0%
Q1 2017$2,230,000
-11.5%
76,7800.0%0.00%0.0%
Q4 2016$2,521,000
-40.3%
76,780
-49.5%
0.00%
-50.0%
Q3 2016$4,220,000
+60.5%
152,034
+62.6%
0.00%
+33.3%
Q2 2016$2,629,000
-49.6%
93,487
-34.9%
0.00%
-50.0%
Q1 2016$5,221,000
+542.2%
143,632
+611.5%
0.01%
+500.0%
Q4 2015$813,000
+52.2%
20,186
+7.7%
0.00%0.0%
Q3 2015$534,000
-14.4%
18,744
-1.0%
0.00%0.0%
Q2 2015$624,000
+7.0%
18,932
-6.6%
0.00%0.0%
Q1 2015$583,000
-48.8%
20,273
-51.5%
0.00%0.0%
Q4 2014$1,139,000
+32.9%
41,837
+4.0%
0.00%0.0%
Q3 2014$857,000
+99.3%
40,237
+110.1%
0.00%0.0%
Q2 2014$430,000
-84.9%
19,148
-83.0%
0.00%
-66.7%
Q1 2014$2,844,000112,5360.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders